Isosorbide Dinitrate

硝酸异山梨酯

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameIsosorbide Dinitrate
Drug Alias Name二硝酸异山梨醇酯dinitrato de isosorbida异山梨醇硝酸酯dinitrate d'isosorbideisosorbidi dinitras +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAtrial natriuretic peptide receptor agonists
TargetsAtrial natriuretic peptide receptor
Therapy Area/IndicationsDiabetic FootMyocardial InfarctionAngina Pectoris +[6] 
Global Approved IndicationsMyocardial InfarctionAngina PectorisMyocardial Ischemia
Approved Indications in ChinaAngina Pectoris
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBausch & Lomb (Singapore) Pvi Ltd
Inactive CompaniesAstrazeneca Pharmaceuticals LpUniversity Of Guadalajara
Active IndicationsMyocardial InfarctionAngina PectorisMyocardial Ischemia
Inactive IndicationsDiabetic FootTinea PedisTinea

Other Information

ATC CodeC01DA08C05AE02
Related LinksWikipediaDrugBankKEGG